Memorial Sloan-Kettering
Sophia sponsored a meeting gathering early adopters, pharma partners, and others to discuss the recently launched MSK-ACCESS, and soon-to-launch MSK-IMPACT kits.
Cancer Centers Look to New NGS-Based 'Frankenpanel' to Get Fast Info on Clinically Actionable Genes
Premium
Memorial Sloan Kettering Cancer Center is among the first healthcare systems to implement the rapid sequencing assay, which can consolidate single-gene tests.
Meta-Analysis Questions FDA Warning on Secondary Cancer Risks With CAR T-Cell Therapies
Researchers analyzed two dozen studies and found similar rates of second primary cancers in patients receiving CAR T-cell and standard therapies.
Biden Cancer Moonshot Announces New Projects Focused on Decreasing Cancer Burden in Africa
Programs aim to improve screening tools and adherence, advance new point-of-care diagnostics, and increase access to precision medicine on the continent.
Immix Biopharma Doses First US Amyloidosis Patient in CAR T-Cell Therapy Trial
The Los Angeles-based company previously tested NXC-201 in AL amyloidosis patients outside of the US in a separate Phase Ib/IIa trial.